TRX
LIVE

Serial Number

79457546

Owner

TauRx Therapeutics Management Ltd.

Filing Date

Jun 22, 2026

Add to watchlist:

No watchlists yet
View on USPTO

TRX Trademark

Serial Number: 79457546

TRX is a trademark filed by TauRx Therapeutics Management Ltd. on June 22, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

TauRx Therapeutics Management Ltd.

395 King Street

Entity Type: 98

Trademark Details

Filing Date

June 22, 2026

Registration Date

Not Registered

Goods & Services

Medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services; research, development and design of drugs and medicine; laboratory and medical laboratory research and development services; clinical research relating to neurodegenerative diseases; exploitation of scientific research and technology, preparation of reports; development of prognostic and diagnostic tools; testing and analysis services for the development of new drugs and medical treatments; consultancy and information services relating to all of the aforesaid.

Medical clinic services; health resort services [medical]; services for the provision of medical facilities; medical services; medical advisory services; medical diagnostic testing, monitoring and reporting services; providing medical information, consultancy and advisory services; medical screening information services featuring reminder alerts regarding medical examinations that individuals should undergo for preventative care purposes; medical screening services in the fields of neurodegenerative and neurological diseases and disorders, malaria and infectious diseases; assessment surveys for health and medical purposes; medical and health care services relating to the diagnosis and treatment of dementia and cognitive disorders; medical analysis services for the diagnostic and prognostic monitoring of neurological diseases; consultancy and information services relating to all the aforesaid.

Pharmaceutical and medical preparations; chemical preparations for medical and pharmaceutical purposes; pharmaceutical and medical preparations for use in relation to neurological diseases and disorders, neurodegenerative diseases and disorders, infectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in relation to neurological diseases and disorders, neurodegenerative diseases and disorders, infectious diseases and malaria.

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 4, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 3, 2026 REPR